Portfolio company
Nilo Therapeuti
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ouro Medicines
This biotechnology firm develops T-cell engager therapies to treat patients living with chronic immune-mediated diseases.
Hillstar Bio
This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.
Egle Therapeutics
This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.
HI-Bio
This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.
Candid Therapeutics
This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.
Re-Aim Therapeutics
This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
COUR Pharma
This clinical-stage biotechnology company develops nanoparticle therapies designed to restore immune tolerance for patients with autoimmune and inflammatory diseases.